ECerS is one of the organisation partners of the H2020 Marie Skłodowska-Curie actions (MSCA) AIMed project.
The AIMed network, consisting of 12 beneficiaries and 6 partner organisations, will develop a range of materials with anti-bacterial properties that are suitable for use on the surfaces of orthopaedic implants. This is in response to the increasing problem of post-operative infection by antibiotic-resistant bacteria. By combining several approaches to disrupt surface biofilm formation, the materials developed by the AIMed network will eventually result in fewer surgical infections, faster recovery of patients, and greatly reduced post-operative healthcare costs. The network will develop novel peptide sequences and ways of binding them to the surfaces of polymers, ceramics and metals. A complementary approach will be the development of metal ion substituted calcium phosphate coatings which can be applied to implants by additive manufacturing techniques. The efficacy of these anti-bacterial surfaces will be further enhanced by laser processing of the material to make it unattractive to biofilms (by altering the roughness and wetting characteristics). The network will carry out a thorough investigation of the properties of the new materials to ensure that they are feasible for use in future implants. This work will include the evaluation of antibacterial action and biocompatibility using appropriate models. Training of the 15 ESR's appointed to the network will be multi-disciplinary and intersectoral, with an emphasis on the need for technology transfer from academic institutions to commercial users.
ECerS will take part to Training & Dissemination and will be in charge of the AIMed Newsletter and AIMed Website and will participate to the organsiation of 2 workshops, 2 summer schools, 1 symposium during one of the ECerS Conferences and 1 day followed by 2 days of network meeting.
The kick-off meeting of AIMed took place on Tuesday 4th February 2020 at the University of Birmingham, UK.